Novo Nordisk shares fall 5.4% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...
Le Lézard21m
U.S. Medical Weight Loss Market Report 2025: The Impact of GLP-1s on Doctors, Hospitals, Clinics and Franchises - ResearchAndMarkets.com
The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete picture of the medical weight loss market in the ...